Healthcare

Butterfly Network Launches Compass AI to Power the Next Generation of POCUS Program Management

Artificial intelligence-powered operating system built for compliant, scalable, revenue-ready POCUS programs.BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--$BFLY #POCUS--Butterfly Network, Inc. (“Butterfly”,…

1 month ago

Veradigm Launches Enhanced Ambient Scribe Capabilities

AI-powered solution includes multilingual support, structured diagnosis code recommendations, and clinical decision insights support tools for Veradigm EHR customersCHICAGO--(BUSINESS WIRE)--Veradigm®…

1 month ago

GE HealthCare announces Flyrcado milestone: Strong pilot results drive broader rollout at CVAUSA

CVAUSA, the largest network of private cardiology groups in the U.S., plans to broadly adopt Flyrcado in line with its…

1 month ago

Dr. Shajira Mohammed Joins Ankle & Foot Centers of America, Serving Emory Midtown and Lithonia Offices

Dr. Mohammed brings advanced training in wound care, sports injuries, and reconstructive foot and ankle surgery to two key metro…

1 month ago

VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a pioneering provider of AI-powered…

1 month ago

CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Cash expected to fund operations into the second half of 2026Company focused on advancing next-generation anti-cancer therapies derived from well-established…

1 month ago

Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump

Study to Deliver Insulin to Internal Testers Wearing Continuous Glucose Monitors SAN DIEGO, CA / ACCESS Newswire / November 17,…

1 month ago

NanoViricides, Inc. Has Filed its Quarterly Report – Subsequent Raise Has Fortified Fiscal Position

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has…

1 month ago

Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs

~Funding supports Phase 3 clinical development of PF614 and continued innovation in abuse- and overdose-resistant analgesics~ SAN DIEGO, CA /…

1 month ago

Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue

Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure…

1 month ago